Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
Public ClinicalTrials.gov record NCT02346721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of treatment with sofosbuvir/velpatasvir (SOF/VEL) in participants with chronic genotype 1, 2, 4, 6 or indeterminate HCV infection who received placebo in the Gilead-sponsored study GS-US-342-1138.
Study identification
- NCT ID
- NCT02346721
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 23, 2015 (Actual)
- Primary completion
- Mar 23, 2016 (Actual)
- Completion
- Jun 15, 2016 (Actual)
- Last update posted
- Nov 16, 2018
2015 – 2016
United States locations
- U.S. sites
- 25
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Long Beach | California | 90822 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Palo Alto | California | 94304 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Diego | California | 92154 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Gainesville | Florida | 32610-0272 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Marietta | Georgia | 30066 | — |
| Not listed | Indianapolis | Indiana | 46237 | — |
| Not listed | Baltimore | Maryland | 21202 | — |
| Not listed | Boston | Massachusetts | 02129 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Pittsburgh | Pennsylvania | 15240 | — |
| Not listed | Providence | Rhode Island | 02905 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Nashville | Tennessee | 37211 | — |
| Not listed | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02346721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02346721 live on ClinicalTrials.gov.